Skip to Main Content

Paper Details

Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding.
Circulation
29
2019
Author NameAffiliation
Renato D LopesDuke University Medical Center
Charles V PollackThomas Jefferson University and Sidney Kimmel Medical College
  • 1 - 2

Datasets

Release 1.2